Yes, early investment is key. Although I think I was 7-8 years early on my initial buy haha! I only sold recently as the spikes were too good an opportunity to not take profit (for me). They generally follow positive news that when not backed up by an increase in revenue, tail off rather rapidly. I'm also very interested in how things pan out in China, but with the By-Health collaboration at such an early stage, I'll risk being out for the potential benefit of a lower buy in price. Obviously, I could miss out big time, but with the SP not likely to drop much further (IMO), I'll likely begin buying back quite soon. Oh, and we mustn't forget the blood pressure/memory trial results and to a lesser extent, the increased revenue from current streams. Although, I have to agree with one of Dampsquibs sentiments, that it's not the easiest product to market to the masses.
It's a shame for others, but I shall continue to call out Trolls such as yourself whenever I see them. It's clear to all that you're only here to antagonise Alfista, and to dress it up as saving people from making poor investment choices, is an insult to their intelligence.
pickledonion, with regard WRN, there are currently multiple legal cases underway due to the tortious inference/corporate sabotage of the company. A tortious interference report "TIR" has been produced in which bulletin board trolls, the worst offenders, are to be pursued as part of the interferents. Whether or not all of this will involve alfista I've no idea, that's for the company to decide. Clearly, with active legal cases underway, it's probably wise to stay out of it and not comment.
My comments here, and on any other board, are just the opinions of one person. Absolutely none have been defamatory, I had a bearish view of Worthington based on my own analysis, and now it is in liquidation, So.....
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.